Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
1shMzxuELYdSev8P
Écouter
